Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer
Raimund Dietze et al.
THERANOSTICS (2021)
miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages
Ismael Sanchez-Gonzalez et al.
CANCER RESEARCH (2020)
Roles of circRNAs in the tumour microenvironment
Qiuge Zhang et al.
MOLECULAR CANCER (2020)
Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer
Meshach Asare-Werehene et al.
CANCER RESEARCH (2020)
The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization
Shuiqing Wu et al.
Aging-US (2020)
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
Mei Song et al.
NATURE COMMUNICATIONS (2020)
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
Min Su et al.
MOLECULAR CANCER (2019)
Hopes and failures in front-line ovarian cancer therapy
Irina Tsibulak et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Molecular mechanisms of drug resistance in ovarian cancer
Leyla Norouzi-Barough et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Function and clinical significance of circRNAs in solid tumors
Yiting Geng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus
Zhenzhou Zhao et al.
ACTA DIABETOLOGICA (2017)
Immune Cell Population in Ovarian Tumor Microenvironment
Dong Li Cai et al.
JOURNAL OF CANCER (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Thomas Worzfeld et al.
FRONTIERS IN ONCOLOGY (2017)
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors
Vinit Kumar et al.
CANCER CELL (2017)
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Elke Pogge von Strandmann et al.
TRENDS IN CANCER (2017)
Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations
Jlenia Guarnerio et al.
CELL (2016)
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans
Lesca M. Holdt et al.
NATURE COMMUNICATIONS (2016)
FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells
Chao Sun et al.
BMC CANCER (2015)
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Yan Li et al.
CELL RESEARCH (2015)
Fibroblast Growth Factor-9 Enhances M2 Macrophage Differentiation and Attenuates Adverse Cardiac Remodeling in the Infarcted Diabetic Heart
Dinender K. Singla et al.
PLOS ONE (2015)
Regulation of circRNA biogenesis
Ling-Ling Chen et al.
RNA BIOLOGY (2015)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Platinum resistant ovarian cancer: What is it, who to treat and how to measure benefit?
Alison Davis et al.
GYNECOLOGIC ONCOLOGY (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
Silke Reinartz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
Jun-Hao Li et al.
NUCLEIC ACIDS RESEARCH (2014)
Tumor-associated macrophages contribute to tumor progression in ovarian cancer
Emily K. Colvin
FRONTIERS IN ONCOLOGY (2014)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
Markus Hafner et al.
CELL (2010)
Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas
ND Hendrix et al.
CANCER RESEARCH (2006)
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580
JG Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)